Some of the proteins that are associated with the gastric cancer (e.g. KRAS, ERBB2, TP53, etc.)are also related to other cancer disease nodes in the graph such as the pancreatic cancer, ovarian cancer, endometrial cancer and cholangiocarcinoma, which means that trifluoperazine may also have a potential against these cancer types, worthy of further exploration. This evidence concerns the gene TP53 and cholangiocarcinoma.